MCO
70
5
MDLZ
26
-2
AA
82
5
LB
33
2
CL
62
4
IP
34
6
TROW
62
6
IRM
44
3
ROP
42
4
TRIP
52
3
KMX
38
-9
CVS
40
3
AVGO
35
-19
A
51
8
CNP
52
3
VTR
69
2
EMR
67
3
MTCH
70
11
VIX
19
-6
DVA
51
2
MCO
70
5
MDLZ
26
-2
AA
82
5
LB
33
2
CL
62
4
IP
34
6
TROW
62
6
IRM
44
3
ROP
42
4
TRIP
52
3
KMX
38
-9
CVS
40
3
AVGO
35
-19
A
51
8
CNP
52
3
VTR
69
2
EMR
67
3
MTCH
70
11
VIX
19
-6
DVA
51
2
Financhill
Back

AbbVie, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
59

ABBV
AbbVie, Inc.

Last Price:
$227.82
Seasonality Move:
3.6%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Buy
59
AbbVie, Inc. (ABBV) is a Buy

Is AbbVie, Inc. a Buy, Sell or Hold?

  • The current AbbVie, Inc. [ABBV] share price is $227.91. The Score for ABBV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABBV Stock Price Chart

What is AbbVie, Inc.'s stock price today?

  • The AbbVie, Inc. share price today is $227.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 52.88 Buy
Chaikin Money Flow: 3204094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (223.75 - 231.39) Buy
Bollinger Bands (100): (209.66 - 231.5) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 225.04 Buy
20-day SMA: 226.14 Buy
50-day SMA: 226.63 Buy
200-day SMA: 205.56 Buy
8-day EMA: 225.63 Buy
20-day EMA: 226 Buy
50-day EMA: 225.06 Buy
200-day EMA: 209.45 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

AbbVie, Inc. Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $3.61 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

AbbVie, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):